The Centers for Medicare and Medicaid Services has announced the first 10 drugs selected for Medicare to negotiate with drug manufacturers to lower their prices.
These 10 drugs are taken by 9 million senior U.S. citizens, according to Domestic Policy Advisor Neera Tanden. They cover chronic conditions like cancer, heart disease, arthritis, and diabetes that can cost up to $14,000 per month.
Lowering the cost of these drugs will help millions of Americans who struggle to afford prescription drugs. "Far too many Americans have to ration prescriptions, cutting a pill in half or taking a lower dose than they need, because their drugs are simply too expensive," Tanden said at a news conference.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.